Generalized pustular psoriasis in a child: observation of long-term combination therapy with etretinate and calcipotriol for 16 years.
Yoshinori Umezawa, Tomotaka Mabuch, Akira Ozawa
Index: Pediatr. Dermatol. 29(2) , 206-8, (2012)
Full Text: HTML
Abstract
Generalized pustular psoriasis (GPP) is a rare condition in young children. It is difficult to treat and may require long-term systemic therapy. We report the long-term course of a 3-year-old boy whose onset of psoriasis dated to age 7 months. He was treated with etretinate and psoralen plus ultraviolet A therapy initially and then with etretinate alone, and at age 12, topical calcipotriol was added. At the age of 19, he had been taking oral retinoids for 16 years, with a mean dose of etretinate of 0.22 mg/kg per day, a total amount of approximately 37 g, without evidence of stunted growth, ligamentous calcification, hyperostosis, or hepatic toxicity.© 2012 Wiley Periodicals, Inc.
Related Compounds
Related Articles:
Systemic retinoids in the management of ichthyoses and related skin types.
2013-01-01
[Dermatol. Ther. 26(1) , 26-38, (2013)]
The effects of alcohol on the metabolism and toxicology of anti-psoriasis drugs.
2012-08-01
[Expert Opin. Drug Metab. Toxicol. 8(8) , 959-72, (2012)]
Acitretin prescribing patterns in women of childbearing potential.
2013-07-01
[Journal. of. Drugs in. Dermatology. 12(7) , 799-802, (2013)]
2013-04-01
[J. Dermatol. 40(4) , 280-1, (2013)]
Primary cutaneous CD30+ lymphoproliferative disorder successfully treated by etretinate.
2012-01-01
[Eur. J. Dermatol. 22(5) , 709-10, (2012)]